Dr Carter completed his PhD in Cellular and Molecular Medicine at the University of Bristol. He studied artificial membrane-binding protein technology for use with enzymes, and is a co-inventor of the core technology now exploited by CytoSeek.
There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.
There is a registration fee to attend the conferences. To visit the exhibition is free.